Trupanion, Inc. (NASDAQ:TRUP) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Trupanion, Inc. (NASDAQ:TRUP) have earned an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $46.60.

TRUP has been the topic of a number of research analyst reports. Piper Sandler dropped their price target on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research note on Thursday, February 20th. Stifel Nicolaus cut their target price on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research note on Thursday, February 20th.

Trupanion Price Performance

NASDAQ:TRUP opened at $37.00 on Monday. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. Trupanion has a 52 week low of $19.69 and a 52 week high of $57.90. The stock’s 50-day moving average price is $41.64 and its 200-day moving average price is $46.74. The stock has a market capitalization of $1.57 billion, a PE ratio of -160.87, a price-to-earnings-growth ratio of 6.02 and a beta of 1.70.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). The business had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. As a group, equities analysts expect that Trupanion will post 0.13 EPS for the current fiscal year.

Insiders Place Their Bets

In other Trupanion news, CEO Margaret Tooth sold 2,294 shares of the firm’s stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total value of $72,008.66. Following the transaction, the chief executive officer now directly owns 118,784 shares of the company’s stock, valued at $3,728,629.76. This trade represents a 1.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Fawwad Qureshi sold 1,373 shares of the business’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total value of $46,984.06. Following the transaction, the chief financial officer now owns 2,416 shares in the company, valued at approximately $82,675.52. This represents a 36.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 25,984 shares of company stock valued at $850,362 in the last 90 days. 5.50% of the stock is owned by insiders.

Hedge Funds Weigh In On Trupanion

A number of institutional investors have recently added to or reduced their stakes in the stock. FMR LLC increased its stake in shares of Trupanion by 55,963.7% in the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after acquiring an additional 1,170,202 shares during the last quarter. Amundi increased its position in Trupanion by 193.2% during the fourth quarter. Amundi now owns 16,828 shares of the financial services provider’s stock worth $784,000 after purchasing an additional 11,088 shares during the last quarter. Barclays PLC raised its stake in Trupanion by 259.2% during the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock worth $2,750,000 after purchasing an additional 47,262 shares during the period. Wealthfront Advisers LLC acquired a new position in Trupanion in the 4th quarter valued at about $845,000. Finally, Proficio Capital Partners LLC purchased a new stake in shares of Trupanion in the 4th quarter valued at approximately $976,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.